Newly Established Specialty Pharmaceuticals Company Investment Opportunity in Los Angeles, USA

- Drug reformulation pharmaceutical company based in Los Angeles.
- Focused on developing drugs through Phase I to IV to achieve FDA approval.
- Primarily directed towards improving health outcomes in the neurosciences and beyond.
- Dedicated to finding innovative and effective treatment solutions to the most challenging ailments related to the Central Nervous System.
- This is done by transforming positive clinical results from decades of hands-on patient care experience into rigorous scientific research.
- The company has 10 patented products in its portfolio, some of which have the potential to generate annual revenues ranging from $200 million to $1 billion per product.
- 4 of these products need to be moved to Phase IIb.
- The products cater to critical healthcare needs in America and are planned to be established through publication on popular channels to showcase the efficacy.
- Also has a network of 70,000 pharmacies, providing a robust distribution platform for its products.
- While the company owns the formulation of its products, the production is outsourced through external laboratories.
- Led by 8 partners with over 100 years of combined professional experience in patient care, clinical research, and entrepreneurship. They bring vast experience in CNS-related drug development, ensuring a strong foundation for the company's operations.